RE:RE:RE:TLT 2022I don't think things are going too well for the cancer drugs like Keytruda, Opdivo, Infinzi etc. Check out the latest stories and headlines of drug makers pulling their products of the shelves, due to lack of results plus flubed trials. "Merck's Keytruda misses mark in small cell lung cancer trial, dasking big expansion hopes". or Bristiol Meyers pulling Opivo because of a liver trial failure, same for AstraZeneca and Infinzi.
Plus IMO, Keytruda just hasn't been that effective, but there really isn't anything else other than Chemo and it's terrible side effects.